Showing results (181-190 of 190) with videos related to
Sort By:
Pageof 19
You have reached the last page of results.This site can display upto 190 results.
The Lancet. Microbe|November 14, 2022
Protection from previous natural infection compared with mRNA vaccination against SARS-CoV-2 infection and severe COVID-19 in Qatar: a retrospective cohort studyHiam Chemaitelly, Houssein H Ayoub, Sawsan AlMukdad, et al.Eclinicalmedicine|August 3, 2023
Population immunity of natural infection, primary-series vaccination, and booster vaccination in Qatar during the COVID-19 pandemic: an observational studySuelen H Qassim, Hiam Chemaitelly, Houssein H Ayoub, et al.Vaccine|April 15, 2024
Effectiveness of two and three doses of COVID-19 mRNA vaccines against infection, symptoms, and severity in the pre-omicron era: A time-dependent gradientLayan Sukik, Hiam Chemaitelly, Houssein H Ayoub, et al.Frontiers in Immunology|September 30, 2022
Effects of SARS-CoV-2 Alpha, Beta, and Delta variants, age, vaccination, and prior infection on infectiousness of SARS-CoV-2 infectionsSuelen H Qassim, Mohammad R Hasan, Patrick Tang, et al.Journal of Travel Medicine|September 30, 2022
Duration of immune protection of SARS-CoV-2 natural infection against reinfectionHiam Chemaitelly, Nico Nagelkerke, Houssein H Ayoub, et al.Plos One|January 31, 2022
Assessing the performance of a serological point-of-care test in measuring detectable antibodies against SARS-CoV-2Peter V Coyle, Reham Awni El Kahlout, Soha R Dargham, et al.International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|September 17, 2023
Short- and longer-term all-cause mortality among SARS-CoV-2- infected individuals and the pull-forward phenomenon in Qatar: a national cohort studyHiam Chemaitelly, Jeremy Samuel Faust, Harlan M Krumholz, et al.Influenza and Other Respiratory Viruses|February 24, 2023
Results from the second WHO external quality assessment for the molecular detection of respiratory syncytial virus, 2019-2020Thomas Williams, Sandra Jackson, Ian Barr, et al.The New England Journal of Medicine|October 4, 2018
Prediction of Susceptibility to First-Line Tuberculosis Drugs by DNA Sequencing, Caroline Allix-Béguec, Irena Arandjelovic, et al.American Journal of Clinical Pathology|January 30, 2009
Check Sample AbstractsDavid Alter, David G Grenache, David S Bosler, et al.Pageof 19